knowledge -WSS

knowledge

author：comprehensive 2025-09-06 04:36:00 - browse：92795

Eli Lilly said Friday it will acquire Versanis Bio, a private company developing an obesity drug that specifically targets fat mass, as the race among pharmaceutical companies to offer weight loss medications intensifies.

The deal indicates Lilly is aiming to diversify its growing portfolio of weight loss therapies, as Versanis’ drug employs an entirely different mechanism than the existing obesity drugs that Lilly is studying. The pharma giant didn’t say how much it would pay Versanis upfront, but said that if the drug meets certain milestones, the total payment could reach $1.9 billion.

Lilly, along with other pharma companies like Novo Nordisk, has been developing products in the class of GLP-1 drugs, which mimic the glucagon-like peptide 1 hormone that helps people feel full. These drugs – including Novo’s Ozempic and Wegovy, and Lilly’s Mounjaro – have exploded in popularity because they lead to significant weight loss.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Eli Lilly to acquire Versanis in heated race for weight loss drugs

WSS

Europe sees delivery challenges ahead on Alzheimer's therapies

MultiPlan and major insurers sued for alleged medical price

Q&A: Jennifer Adair on making gene therapy available globally

MultiPlan and major insurers sued for alleged medical price

Grail faces three suits alleging harassment, retaliation

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

leisure time

knowledge

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The new HIV moral panic

Sports medicine is finally prioritizing gender equality

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

Novavax promises a turnaround & Lilly roils the obesity market

MultiPlan and major insurers sued for alleged medical price

Dobbs anniversary: the lost opportunity of abortion as health care

Global childhood vaccinations edge closer to pre

Moonlake's readout produced a cash windfall. Risks remain

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

hotspot

Mike Pence clashes with Tucker Carlson in Iowa

Orangutan used medicinal plant to treat wound, first time ever seen

J&J expands global access to TB drug amid advocacy campaign

Getting Alzheimer's drug Leqembi to patients can be a challenge

Cue Health's Covid

Federal judge rules Oregon’s tough new gun law is constitutional

2019年版第五套人民币1元硬币为什么改变规格？　　对此，中国人民银行介绍，2019年版第五套人民币1元硬币直径由25毫米调整为22.25毫米。

leisure time

leisure time

hotspot

leisure time

knowledge

hotspot

hotspot

Mike Pence clashes with Tucker Carlson in Iowa

Orangutan used medicinal plant to treat wound, first time ever seen

J&J expands global access to TB drug amid advocacy campaign

Getting Alzheimer's drug Leqembi to patients can be a challenge

Cue Health's Covid

Federal judge rules Oregon’s tough new gun law is constitutional

2019年版第五套人民币1元硬币为什么改变规格？ 对此，中国人民银行介绍，2019年版第五套人民币1元硬币直径由25毫米调整为22.25毫米。

leisure time

leisure time

hotspot

　　2019年版第五套人民币1元硬币为什么改变规格？　　对此，中国人民银行介绍，2019年版第五套人民币1元硬币直径由25毫米调整为22.25毫米。